Dirui Industrial Co (300396.SZ) Stock Price

Dirui Industrial Co., Ltd. generates revenue through the research, development, production, and sale of medical testing instruments and supporting test paper reagents. The company's main products include urine analysis series, urinary composition analysis series, biochemical analysis series, and blood cell analysis series, which are used for routine physical examinations and diagnosis of illness. Domestic and overseas markets are the primary distribution channels for these products, with the firm targeting healthcare providers and diagnostic laboratories that require reliable testing solutions for patient care. The company's product portfolio focuses on diagnostic tools essential for clinical settings, serving both domestic and international healthcare sectors. By offering a comprehensive range of testing instruments and reagents, Dirui Industrial addresses the needs of medical facilities seeking efficient and accurate diagnostic capabilities. The firm's products are integral to routine health screenings and medical diagnostics, supporting healthcare professionals in patient assessment and treatment planning. Dirui Industrial's business model relies on direct sales to healthcare institutions and distributors operating within domestic and overseas markets. The company's products are positioned as essential diagnostic tools for routine physical examinations and illness diagnosis, appealing to a broad spectrum of medical practitioners and facilities. This approach ensures consistent demand for their instruments and reagents across various healthcare environments.